← SynDRA
LDN-212854
SynDRA canonical compound SYN0087399 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ACVR1 |
|---|
| Mechanism of action | Bone morphogenic protein inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Bone morphogenic protein inhibitor
Cross-references
Synonyms
- RefChem:152602
- LDN212854
- BMP Inhibitor III
- MFCD28099808
- orb1307185
- SCHEMBL16025991
- SCHEMBL29391702
- EX-A425
- CHEBI:229962
- BDBM102618
- GLXC-03718
- HMS3653M11
- HHC59726
- s7147
- AKOS026750252
- CCG-268725
- CS-3212
- SB19484
- LDN-212854?
- NCGC00386324-08
- NCGC00386324-10
- AC-31402
- AS-16555
- DA-33440
- HY-15897
- SW220045-1
- VU0472597-1
- C72696
- BRD-K59831625-001-01-6
- BRD-K59831625-001-02-4
- 5-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline
- LDN 212854
Look up LDN-212854 in the interactive SynDRA portal →